What's in Beijing Continent Pharmaceutical Co, Ltd.'s pipeline?

Beijing Continent Pharmaceutical Co, Ltd. has 12 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 4 in Phase 2, 4 in Phase 1.

Which companies overlap with Beijing Continent Pharmaceutical Co, Ltd.'s portfolio?

Top competitors by shared drug class: Centro Dermatológico Dr. Ladislao de la Pascua, Janssen Research & Development, LLC, Beijing Tiantan Hospital, Bristol-Myers Squibb, Eli Lilly and Company.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/beijing-continent-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Beijing Continent Pharmaceutical Co, Ltd. — Portfolio Competitive Intelligence Brief

Beijing Continent Pharmaceutical Co, Ltd. pipeline: 0 marketed, 0 filed, 4 Phase 3, 4 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 4 Phase 2 4 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Hydronidone capsules	Hydronidone capsules	phase 3	Corticosteroid	Glucocorticoid receptor	Immunology/Inflammation
The placebo capsules	The placebo capsules	phase 3
Hydronidone (Placebo Group)	Hydronidone (Placebo Group)	phase 3
Hydronidone (270mg)	Hydronidone (270mg)	phase 3	Corticosteroid	Glucocorticoid receptor	Immunology/Rheumatology

Therapeutic area mix

Immunology/Inflammation · 1
Immunology/Rheumatology · 1
Oncology · 1
Respiratory · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Centro Dermatológico Dr. Ladislao de la Pascua · 2 shared drug classes
Janssen Research & Development, LLC · 2 shared drug classes
Beijing Tiantan Hospital · 2 shared drug classes
Bristol-Myers Squibb · 2 shared drug classes
Eli Lilly and Company · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
Assistance Publique - Hôpitaux de Paris · 2 shared drug classes
Nantes University Hospital · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Beijing Continent Pharmaceutical Co, Ltd.:

Cite this brief

Drug Landscape (2026). Beijing Continent Pharmaceutical Co, Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/beijing-continent-pharmaceutical-co-ltd. Accessed 2026-05-16.